{ "entity_id": "O-000875", "folder": "National-Blood-Authority", "name": "National Blood Authority", "type": "Non-corporate Commonwealth Entity", "jurisdiction": "Commonwealth", "portfolio": "Health, Disability and Ageing", "website": "http://www.blood.gov.au", "data_status": "rich", "completeness": { "has_strategy_brief": true, "has_strategy_structured": true, "has_vision": true, "has_kpi_targets": true, "has_kpi_results": true, "has_strategy_overview": true, "has_legislation_text": true, "has_legislation_structured": true, "has_global_initiatives_text": true, "has_global_initiatives_structured": true, "n_global_initiatives": 10, "has_ideas": true, "has_artifacts": true, "n_ideas": 8, "n_legislation": 8, "n_artifacts": 2, "n_kpi_targets": 4, "n_kpi_results": 4, "n_outcomes": 1, "verified_own_data": true }, "strategy_profile": { "status": "published", "confidence": "high", "summary": "To provide a safe, secure and affordable supply of blood and blood-related products and services. To drive performance improvement in the Australian blood sector. To promote best practice in managing and using of blood and blood-related products and services. To develop and provide policy advice on the sustainability of the blood sector. To be a high-performing organisation. [CP p.9]", "official_site_url": "http://www.blood.gov.au", "source_documents": [ { "type": "corporate_plan", "title": "Read the Corporate Plan here (Opens in a new tab/window)", "url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "period": "2025-26", "confidence": "high" } ], "purpose": { "text": "To provide a safe, secure and affordable supply of blood and blood-related products and services. To drive performance improvement in the Australian blood sector. To promote best practice in managing and using of blood and blood-related products and services. To develop and provide policy advice on the sustainability of the blood sector. To be a high-performing organisation. [CP p.9]", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": 9, "source_deep_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf#page=9" }, "vision": { "text": "To save and improve Australian lives and patient outcomes through a world-class blood supply. [CP p.9]", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": 9, "source_deep_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf#page=9" }, "strategic_priorities": [ { "title": "To provide an adequate, safe, secure and affordable supply of blood products, blood related products and blood related s", "description": "To provide an adequate, safe, secure and affordable supply of blood products, blood related products and blood related services in Australia.", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": 10, "source_deep_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf#page=10" }, { "title": "To promote the safe, high-quality management and use of blood products, blood related products and blood related service", "description": "To promote the safe, high-quality management and use of blood products, blood related products and blood related services in Australia.", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": 10, "source_deep_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf#page=10" } ], "values": [ { "name": "Safe", "description": "", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": null }, { "name": "Secure", "description": "", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": null }, { "name": "Affordable", "description": "", "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": null } ], "outcomes": [ { "name": "Outcome 1: Access to a secure supply of safe and affordable blood products", "description": "Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best-practice standards within agreed funding policies under the national blood arrangements. [CP p.37]", "activities": [ "Developing a National Supply Plan and Budget (NSP&B) each year", "Negotiating and managing national contracts with suppliers of blood and blood products" ], "source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "source_page": 37, "source_deep_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf#page=37" } ], "performance_measures": [ { "code": "A safe, secure and affordable supply of blood and blood-related products", "measure": "Blood and blood-related products are available to meet clinical requirements.", "target": "<5% variation within 5% of the National Supply Plan & Budget approved by governments.", "latest_result": "N/A", "status": "N/A", "target_source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "target_source_page": 34, "result_source_url": "", "result_source_page": null }, { "code": "Effective management of events that activate the National Blood Supply Contingency Plan", "measure": "Events that activate the National Blood Supply Contingency Plan, if any, are managed effectively and efficiently by the NBA.", "target": "N/A", "latest_result": "N/A", "status": "N/A", "target_source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "target_source_page": 34, "result_source_url": "", "result_source_page": null }, { "code": "Appropriate access and use of immunoglobulin (Ig)", "measure": "Ig demand under approved criteria.", "target": "<8% growth in Ig demand under approved access criteria.", "latest_result": "N/A", "status": "N/A", "target_source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "target_source_page": 34, "result_source_url": "", "result_source_page": null }, { "code": "National performance reporting and benchmarking", "measure": "Publish performance reporting and benchmarking information on the NBA website for the blood sector community.", "target": "N/A", "latest_result": "N/A", "status": "N/A", "target_source_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "target_source_page": 34, "result_source_url": "", "result_source_page": null } ], "document_alignment_terms": { "must_support": [ "To provide a safe, secure and affordable supply of blood and blood-related products and services. To drive performance improvement in the Australian blood sector. To promote best p", "To save and improve Australian lives and patient outcomes through a world-class blood supply. [CP p.9]", "To provide an adequate, safe, secure and affordable supply of blood products, blood related products and blood related services in Australia.", "To promote the safe, high-quality management and use of blood products, blood related products and blood related services in Australia." ], "watch_terms": [ "Blood and blood-related products are available to meet clinical requirements.", "Events that activate the National Blood Supply Contingency Plan, if any, are managed effectively and efficiently by the NBA.", "Ig demand under approved criteria.", "Publish performance reporting and benchmarking information on the NBA website for the blood sector community." ], "avoid_claiming_without_evidence": [] }, "review_note": "" }, "global_initiatives": { "focus_areas": [ "Supply of safe and secure blood products", "Management and use of immunoglobulins", "National performance reporting and benchmarking" ], "initiatives": [ { "name": "Blood Safety and Supply Initiative", "focus_area": "Supply of safe and secure blood products", "jurisdiction": "United States", "run_by": "Food and Drug Administration (FDA)", "year": "1992", "status": "Active", "what_it_does": "The FDA oversees the safety and supply of blood and blood products in the U.S., ensuring rigorous standards for blood collection, processing, and distribution.", "why_relevant": "", "find_more_title": "Blood Safety and Supply Initiative", "find_more_url": "https://www.google.com/search?q=FDA+blood+safety+and+supply+initiative" }, { "name": "European Blood Alliance", "focus_area": "Supply of safe and secure blood products", "jurisdiction": "European Union", "run_by": "European Commission Directorate-General for Health and Food Safety", "year": "2000", "status": "Active", "what_it_does": "The European Blood Alliance coordinates blood safety and supply across EU member states, promoting best practices and harmonizing regulations.", "why_relevant": "", "find_more_title": "European Blood Alliance", "find_more_url": "https://www.google.com/search?q=European+Blood+Alliance" }, { "name": "Canadian Blood Services", "focus_area": "Supply of safe and secure blood products", "jurisdiction": "Canada", "run_by": "Canadian Blood Services", "year": "1998", "status": "Active", "what_it_does": "Canadian Blood Services manages the national blood system, focusing on the safety, availability, and sustainability of blood supplies.", "why_relevant": "", "find_more_title": "Canadian Blood Services", "find_more_url": "https://www.google.com/search?q=Canadian+Blood+Services" }, { "name": "National Health Service Blood and Transplant", "focus_area": "Supply of safe and secure blood products", "jurisdiction": "United Kingdom", "run_by": "NHS Blood and Transplant", "year": "2005", "status": "Active", "what_it_does": "NHS Blood and Transplant manages the blood supply chain in the UK, ensuring safe and efficient blood collection, testing, and distribution.", "why_relevant": "", "find_more_title": "NHS Blood and Transplant", "find_more_url": "https://www.google.com/search?q=NHS+Blood+and+Transplant" }, { "name": "National Institute of Health (NIH) Immunoglobulin Program", "focus_area": "Management and use of immunoglobulins", "jurisdiction": "United States", "run_by": "National Institute of Health (NIH)", "year": "1982", "status": "Active", "what_it_does": "The NIH Immunoglobulin Program supplies high-quality immunoglobulins for research and clinical use, ensuring appropriate access and use.", "why_relevant": "", "find_more_title": "NIH Immunoglobulin Program", "find_more_url": "https://www.google.com/search?q=NIH+Immunoglobulin+Program" }, { "name": "New Zealand Blood Service Immunoglobulin Program", "focus_area": "Management and use of immunoglobulins", "jurisdiction": "New Zealand", "run_by": "New Zealand Blood Service", "year": "1990", "status": "Active", "what_it_does": "The New Zealand Blood Service manages the supply and distribution of immunoglobulins, ensuring appropriate access and use.", "why_relevant": "", "find_more_title": "New Zealand Blood Service Immunoglobulin Program", "find_more_url": "https://www.google.com/search?q=New+Zealand+Blood+Service+Immunoglobulin+Program" }, { "name": "Australian Red Cross Lifeblood Immunoglobulin Program", "focus_area": "Management and use of immunoglobulins", "jurisdiction": "Australia", "run_by": "Australian Red Cross Lifeblood", "year": "1985", "status": "Active", "what_it_does": "Australian Red Cross Lifeblood manages the supply and distribution of immunoglobulins, ensuring appropriate access and use.", "why_relevant": "", "find_more_title": "Australian Red Cross Lifeblood Immunoglobulin Program", "find_more_url": "https://www.google.com/search?q=Australian+Red+Cross+Lifeblood+Immunoglobulin+Program" }, { "name": "Australian Red Cross Lifeblood Performance Reporting", "focus_area": "National performance reporting and benchmarking", "jurisdiction": "Australia", "run_by": "Australian Red Cross Lifeblood", "year": "2000", "status": "Active", "what_it_does": "Australian Red Cross Lifeblood publishes performance reports and benchmarks for the national blood sector.", "why_relevant": "", "find_more_title": "Australian Red Cross Lifeblood Performance Reporting", "find_more_url": "https://www.google.com/search?q=Australian+Red+Cross+Lifeblood+Performance+Reporting" }, { "name": "Health Canada Blood System Performance Reports", "focus_area": "National performance reporting and benchmarking", "jurisdiction": "Canada", "run_by": "Health Canada", "year": "2005", "status": "Active", "what_it_does": "Health Canada publishes comprehensive performance reports and benchmarks for Canada’s blood system.", "why_relevant": "", "find_more_title": "Health Canada Blood System Performance Reports", "find_more_url": "https://www.google.com/search?q=Health+Canada+Blood+System+Performance+Reports" }, { "name": "NHS Blood and Transplant Performance Benchmarking", "focus_area": "National performance reporting and benchmarking", "jurisdiction": "United Kingdom", "run_by": "NHS Blood and Transplant", "year": "2008", "status": "Active", "what_it_does": "NHS Blood and Transplant publishes performance reports and benchmarks for the UK’s blood sector.", "why_relevant": "", "find_more_title": "NHS Blood and Transplant Performance Benchmarking", "find_more_url": "https://www.google.com/search?q=NHS+Blood+and+Transplant+Performance+Benchmarking" } ], "count": 10 }, "strategy": { "reporting_period": "2024-25", "corporate_plan_period": "2025-26", "vision": "To save and improve Australian lives and patient outcomes through a world-class blood supply. [CP p.9]", "vision_source_page": 9, "purposes": "To provide a safe, secure and affordable supply of blood and blood-related products and services. To drive performance improvement in the Australian blood sector. To promote best practice in managing and using of blood and blood-related products and services. To develop and provide policy advice on the sustainability of the blood sector. To be a high-performing organisation. [CP p.9]", "purposes_source_page": 9, "how_we_deliver": "The NBA manages and coordinates arrangements for the supply of blood, blood products and blood related services on behalf of all Australian governments in line with the National Blood Agreement. [CP p.10]", "how_we_deliver_source_page": 10, "government_priorities": [ { "text": "To provide an adequate, safe, secure and affordable supply of blood products, blood related products and blood related services in Australia.", "source_page": 10 }, { "text": "To promote the safe, high-quality management and use of blood products, blood related products and blood related services in Australia.", "source_page": 10 } ], "outcomes": [ { "name": "Outcome 1: Access to a secure supply of safe and affordable blood products", "description": "Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best-practice standards within agreed funding policies under the national blood arrangements. [CP p.37]", "key_activities": [ "Developing a National Supply Plan and Budget (NSP&B) each year", "Negotiating and managing national contracts with suppliers of blood and blood products" ], "source_page": 37 } ], "values": [ "Safe", "Secure", "Affordable" ], "values_framework_name": null, "kpi_targets_2025_26": [ { "code": "A safe, secure and affordable supply of blood and blood-related products", "measure": "Blood and blood-related products are available to meet clinical requirements.", "target": "<5% variation within 5% of the National Supply Plan & Budget approved by governments.", "source_page": 34 }, { "code": "Effective management of events that activate the National Blood Supply Contingency Plan", "measure": "Events that activate the National Blood Supply Contingency Plan, if any, are managed effectively and efficiently by the NBA.", "target": "N/A", "source_page": 34 }, { "code": "Appropriate access and use of immunoglobulin (Ig)", "measure": "Ig demand under approved criteria.", "target": "<8% growth in Ig demand under approved access criteria.", "source_page": 34 }, { "code": "National performance reporting and benchmarking", "measure": "Publish performance reporting and benchmarking information on the NBA website for the blood sector community.", "target": "N/A", "source_page": 34 } ], "kpi_results_2024_25": [ { "code": "A safe, secure and affordable supply of blood and blood-related products", "measure": "Blood and blood-related products are available to meet clinical requirements.", "result": "N/A", "status": "N/A", "source_page": null }, { "code": "Effective management of events that activate the National Blood Supply Contingency Plan", "measure": "Events that activate the National Blood Supply Contingency Plan, if any, are managed effectively and efficiently by the NBA.", "result": "N/A", "status": "N/A", "source_page": null }, { "code": "Appropriate access and use of immunoglobulin (Ig)", "measure": "Ig demand under approved criteria.", "result": "N/A", "status": "N/A", "source_page": null }, { "code": "National performance reporting and benchmarking", "measure": "Publish performance reporting and benchmarking information on the NBA website for the blood sector community.", "result": "N/A", "status": "N/A", "source_page": null } ], "_source_urls": { "annual_report_url": "", "corporate_plan_url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf" } }, "ideas": [ { "id": "blood-supply-contingency-plan", "category": "Case Processing", "title": "Enhance Blood Supply Contingency Plan", "scale": "Large", "impact": "High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Healthcare providers and patients", "description": "Revise and update the National Blood Supply Contingency Plan to include more robust and flexible response strategies for blood supply disruptions.", "evidence_quote": "'Events that activate the National Blood Supply Contingency Plan, if any, are managed effectively and efficiently by the NBA.' [CP p.34]", "source": "corporate-plans/2025-26.pages.jsonl", "implementation_steps": [ "Conduct a comprehensive review of current contingency plans", "Engage with stakeholders to identify potential supply disruptions", "Develop flexible response strategies", "Test and refine the updated plan through simulations" ], "risks_to_manage": [ "Resistance from stakeholders to new strategies", "Increased costs for plan development and testing", "Potential delays in updating the plan" ] }, { "id": "immunoglobulin-demand-monitoring", "category": "Case Processing", "title": "Implement Advanced Ig Demand Monitoring", "scale": "Small", "impact": "Medium", "effort": "Medium", "proof": "Evidence-backed", "beneficiaries": "Healthcare providers and patients", "description": "Adopt advanced data analytics to better monitor and predict immunoglobulin (Ig) demand, ensuring timely supply adjustments.", "evidence_quote": "<8% growth in Ig demand under approved criteria [CP p.34]", "source": "corporate-plans/2025-26.pages.jsonl", "implementation_steps": [ "Identify and procure suitable data analytics tools", "Train staff on new monitoring techniques", "Integrate analytics into existing supply chain management systems", "Regularly review and refine the monitoring system" ], "risks_to_manage": [ "Initial resistance to new technology", "Data privacy and security concerns", "Cost of new tools and training" ] }, { "id": "performance-reporting-website", "category": "Data & Performance", "title": "Enhance NBA Performance Reporting Website", "scale": "Medium", "impact": "High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Blood sector community", "description": "Upgrade the NBA website to provide more interactive and user-friendly performance reporting and benchmarking tools for the blood sector.", "evidence_quote": "Publish performance reporting and benchmarking information on the NBA website for the blood sector community. [CP p.34]", "source": "corporate-plans/2025-26.pages.jsonl", "implementation_steps": [ "Conduct user experience research", "Design and develop an interactive reporting platform", "Integrate existing performance data into the new platform", "Launch and promote the updated website" ], "risks_to_manage": [ "User adoption issues", "Technical integration challenges", "Increased maintenance and support costs" ] }, { "id": "blood-donation-campaign", "category": "Citizen Participation", "title": "Launch Targeted Blood Donation Campaigns", "scale": "Small", "impact": "Medium", "effort": "Medium", "proof": "Evidence-backed", "beneficiaries": "Blood donation recipients", "description": "Initiate targeted social media campaigns to encourage blood donations during low supply periods.", "evidence_quote": "'Provide a safe, secure and affordable supply of blood and blood-related products are available to meet clinical requirements.' [AR p.X]", "source": "annual-reports/2024-25.pdf", "implementation_steps": [ "Identify peak low supply periods", "Develop campaign content and social media strategy", "Partner with local health organizations for campaign support", "Monitor and evaluate campaign effectiveness" ], "risks_to_manage": [ "Campaign reach and engagement", "Coordination with local health organizations", "Budget constraints" ] }, { "id": "staff-training-program", "category": "Capability Building", "title": "Implement Advanced Staff Training Program", "scale": "Large", "impact": "High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Staff and patients", "description": "Develop and implement a comprehensive advanced training program for staff to enhance their skills in blood procurement and management.", "evidence_quote": "'To be a high-performing organisation.' [CP p.9]", "source": "corporate-plans/2025-26.pages.jsonl", "implementation_steps": [ "Identify key skills gaps", "Design and develop advanced training modules", "Conduct pilot training sessions", "Roll out the program and continuously evaluate its effectiveness" ], "risks_to_manage": [ "Resistance to new training requirements", "Cost of program development and delivery", "Time away from regular duties" ] }, { "id": "overseas-blood-procurement", "category": "Procurement & Delivery", "title": "Adopt Overseas Blood Procurement Practices", "scale": "Large", "impact": "Very High", "effort": "High", "proof": "Overseas case-study evidence", "beneficiaries": "Healthcare providers and patients", "description": "Study and adopt successful overseas blood procurement practices to improve efficiency and cost-effectiveness.", "evidence_quote": "'World Bank Governance Global Practice' [source-text/association-worldbank.org-governance.txt]", "source": "global-ideas/worldbank-governance.txt", "implementation_steps": [ "Conduct a comparative analysis of overseas practices", "Identify best practices to adopt", "Develop a plan for integrating new practices", "Monitor and evaluate the impact of changes" ], "risks_to_manage": [ "Regulatory compliance issues", "Cultural and logistical challenges", "Potential disruptions in supply chain" ] }, { "id": "blood-donor-feedback", "category": "Citizen Participation", "title": "Implement Donor Feedback Mechanism", "scale": "Small", "impact": "Medium", "effort": "Medium", "proof": "Evidence-backed", "beneficiaries": "Blood donors", "description": "Create a structured feedback mechanism for blood donors to improve donor experience and retention.", "evidence_quote": "'Promote best practice in managing and using of blood and blood-related products and services in Australia.' [CP p.9]", "source": "corporate-plans/2025-26.pages.jsonl", "implementation_steps": [ "Design a feedback collection tool", "Implement the tool in donor registration and follow-up processes", "Regularly review feedback and make improvements", "Report findings to stakeholders" ], "risks_to_manage": [ "Low feedback participation", "Managing negative feedback", "Cost of implementation" ] }, { "id": "risk-management-policy", "category": "Risk & Assurance", "title": "Revise Risk Management Policy", "scale": "Large", "impact": "High", "effort": "High", "proof": "Evidence-backed", "beneficiaries": "Staff and patients", "description": "Revise the current risk management policy to include more detailed risk assessment and mitigation strategies.", "evidence_quote": "'The NBA’s risk management arrangements in compliance with Section 16 of the Public Governance, Performance and Accountability Act 2013 (PGPA Act) are established in our Risk Management Policy...' [AR p.30]", "source": "other-pdfs/NBA0920-20-E2-80-93-20NBA-20Annual-20Report-202024-E2-80-9325-20-28Working-20fil.pages.jsonl", "implementation_steps": [ "Conduct a comprehensive risk assessment", "Develop updated risk management strategies", "Train staff on new policies", "Regularly review and update the policy" ], "risks_to_manage": [ "Resistance to policy changes", "Increased administrative burden", "Potential gaps in risk coverage" ] } ], "legislation_administered": [ { "title": "National Blood Authority Act 2003", "year": "2003", "type": "Act", "role": "The entity administers and manages national blood arrangements under this Act.", "register_url": "https://www.legislation.gov.au/search?query=National%20Blood%20Authority%20Act%202003" }, { "title": "National Blood Agreement", "year": "2002", "type": "Agreement", "role": "The entity manages and coordinates the supply of blood and blood products in line with this Agreement.", "register_url": "https://www.legislation.gov.au/search?query=National%20Blood%20Agreement" }, { "title": "Domestic Supply Policy (for the Australian Blood Sector)", "year": "Not specified", "type": "Policy", "role": "The entity develops and manages policies to ensure an adequate supply of domestic blood products.", "register_url": "https://www.legislation.gov.au/search?query=Domestic%20Supply%20Policy%20for%20the%20Australian%20Blood%20Sector" }, { "title": "Onshore Fractionation Policy", "year": "Not specified", "type": "Policy", "role": "The entity develops and manages policies for the fractionation of blood products onshore.", "register_url": "https://www.legislation.gov.au/search?query=Onshore%20Fractionation%20Policy" }, { "title": "Overseas Supply Policy", "year": "Not specified", "type": "Policy", "role": "The entity manages policies for sourcing blood products from overseas.", "register_url": "https://www.legislation.gov.au/search?query=Overseas%20Supply%20Policy" }, { "title": "Ministers’ Stewardship Statement (for health providers)", "year": "Not specified", "type": "Statement", "role": "The entity supports the work of Australian governments to improve the governance of blood products.", "register_url": "https://www.legislation.gov.au/search?query=Ministers%27%20Stewardship%20Statement%20for%20health%20providers" }, { "title": "Criteria for the Clinical Use of Immunoglobulin in Australia", "year": "Not specified", "type": "Criteria", "role": "The entity develops criteria for the clinical use of immunoglobulin products.", "register_url": "https://www.legislation.gov.au/search?query=Criteria%20for%20the%20Clinical%20Use%20of%20Immunoglobulin%20in%20Australia" }, { "title": "National Policy: Access to Government-Funded Immunoglobulin Products in Australia", "year": "Not specified", "type": "Policy", "role": "The entity manages access to government-funded immunoglobulin products.", "register_url": "https://www.legislation.gov.au/search?query=National%20Policy%3A%20Access%20to%20Government-Funded%20Immunoglobulin%20Products%20in%20Australia" } ], "artifacts": [ { "category": "corporate-plans", "year": "2025-26", "url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "file": "corporate-plans/2025-26.pdf", "bytes": 6435684, "link_text": "Read the Corporate Plan here (Opens in a new tab/window)" }, { "category": "other-pdfs", "year": "2025", "url": "https://www.blood.gov.au/sites/default/files/documents/2025-10/NBA0920%20%E2%80%93%20NBA%20Annual%20Report%202024%E2%80%9325%20%28Working%20file%29%20-%20WCAG.pdf", "file": "other-pdfs/NBA0920-20-E2-80-93-20NBA-20Annual-20Report-202024-E2-80-9325-20-28Working-20fil.pdf", "bytes": 3522745, "link_text": "Read the report here (Opens in a new tab/window)" } ], "_meta": { "snapshot_built_at": "2026-05-14T02:13:14+00:00", "strategy_brief_meta": { "model": "nova-micro", "folder": "National-Blood-Authority", "annual_report": { "file": null, "url": "", "year": null }, "corporate_plan": { "file": "corporate-plans\\2025-26.txt", "url": "https://www.blood.gov.au/sites/default/files/documents/2025-08/NBA%20Corporate%20Plan%202025-26%20-%20Final.pdf", "year": "2025-26" }, "usage": { "input_tokens": 12175, "output_tokens": 1053, "total_tokens": 13228, "model": "nova-micro" }, "cost_usd": 0.000573545, "elapsed_seconds": 22.49, "generated_at": "2026-05-13T04:07:31+00:00" }, "ideas_manifest": { "folder": "National-Blood-Authority", "entity_id": "O-000875", "model": "nova-micro", "generated_at": "2026-05-13T03:20:26+00:00", "elapsed_seconds": 5.82, "usage": { "input_tokens": 4472, "output_tokens": 1973, "total_tokens": 6445, "model": "nova-micro" }, "cost_usd": 0.00043274000000000003, "n_ideas": 8, "inputs": { "overview_chars": 4427, "brief_chars": 930, "legis_chars": 27790 } }, "global_intel_meta": { "folder": "National-Blood-Authority", "entity_id": "O-000875", "model": "nova-micro", "usage": { "input_tokens": 1510, "output_tokens": 1476, "total_tokens": 2986, "model": "nova-micro" }, "cost_usd": 0.00025949, "elapsed_seconds": 4.41, "generated_at": "2026-05-13T03:20:36+00:00" } } }